TickerFactsScreenerDevelopers

KalVista Pharmaceuticals, Inc. (KALV) — Total Assets

Annual figures by fiscal year, from SEC filings.

2014: $6.64M2015: $56.79M2016: $24.75M2017: $34.34M2018: $61.39M2019: $118.13M2020: $92.53M2021: $272.01M2022: $203.88M2023: $183.20M2024: $235.40M2025: $335.38M$335.38M
2014Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$335.38M+42.5%
2024$235.40M+28.5%
2023$183.20M-10.1%
2022$203.88M-25.0%
2021$272.01M+194.0%
2020$92.53M-21.7%
2019$118.13M+92.4%
2018$61.39M+78.7%
2017$34.34M+38.8%
2016$24.75M-56.4%
2015$56.79M+754.8%
2014$6.64M—